Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia.

Kong CS, Balzer BL, Troxell ML, Patterson BK, Longacre TA.

Am J Surg Pathol. 2007 Jan;31(1):33-43.

PMID:
17197917
2.

Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsies.

Mulvany NJ, Allen DG, Wilson SM.

Pathology. 2008 Jun;40(4):335-44. doi: 10.1080/00313020802035907. Review.

PMID:
18446622
3.

Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature.

Yildiz IZ, Usubütün A, Firat P, Ayhan A, Küçükali T.

Pathol Res Pract. 2007;203(6):445-9. Epub 2007 May 31. Review.

PMID:
17543474
4.

p16 expression in the female genital tract and its value in diagnosis.

O'Neill CJ, McCluggage WG.

Adv Anat Pathol. 2006 Jan;13(1):8-15. Review.

PMID:
16462152
5.

Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma.

Dehn D, Torkko KC, Shroyer KR.

Cancer. 2007 Feb 25;111(1):1-14. Review.

6.

P16INK4a immunocytochemistry/immunohistochemistry: need for scoring uniformization to be clinically useful in gynecological pathology.

van Bogaert LJ.

Ann Diagn Pathol. 2012 Oct;16(5):422-6. doi: 10.1016/j.anndiagpath.2012.03.006. Epub 2012 Apr 24. Review.

PMID:
22537665
7.

Genotypic mapping of HPV and assessment of EBV prevalence in endocervical lesions.

O'Leary JJ, Landers RJ, Crowley M, Healy I, Kealy WF, Hogan J, Cullinane C, Kelehan P, Doyle CT.

J Clin Pathol. 1997 Nov;50(11):904-10. Review.

8.

Immunohistochemistry and in situ hybridization for the diagnosis and classification of squamous lesions of the anogenital region.

Pirog EC.

Semin Diagn Pathol. 2015 Sep;32(5):409-18. doi: 10.1053/j.semdp.2015.02.015. Epub 2015 Feb 7. Review.

PMID:
25862555
9.

Different patterns of p16 immunoreactivity in cervical biopsies: correlation to lesion grade and HPV detection, with a review of the literature.

Kostopoulou E, Samara M, Kollia P, Zacharouli K, Mademtzis I, Daponte A, Messinis IE, Koukoulis G.

Eur J Gynaecol Oncol. 2011;32(1):54-61. Review.

PMID:
21446326
10.
11.

[Precancerous lesions of the cervix. Biomarkers in cytological diagnosis].

Schmidt D.

Pathologe. 2011 Nov;32(6):484-90. doi: 10.1007/s00292-011-1478-3. Review. German.

PMID:
21922253
12.

Commercially available assays for multiplex detection of alpha human papillomaviruses.

Poljak M, Kocjan BJ.

Expert Rev Anti Infect Ther. 2010 Oct;8(10):1139-62. doi: 10.1586/eri.10.104. Review.

PMID:
20954880
13.

Histology of cervical intraepithelial neoplasia and the role of biomarkers.

Martin CM, O'Leary JJ.

Best Pract Res Clin Obstet Gynaecol. 2011 Oct;25(5):605-15. doi: 10.1016/j.bpobgyn.2011.04.005. Epub 2011 Jun 1. Review.

PMID:
21636328
14.

Biomarkers for cervical cancer screening: the role of p16(INK4a) to highlight transforming HPV infections.

von Knebel Doeberitz M, Reuschenbach M, Schmidt D, Bergeron C.

Expert Rev Proteomics. 2012 Apr;9(2):149-63. doi: 10.1586/epr.12.13. Review.

PMID:
22462787
15.

Our approach to squamous intraepithelial lesions of the uterine cervix.

Kalof AN, Cooper K.

J Clin Pathol. 2007 May;60(5):449-55. Epub 2006 Oct 17. Review. No abstract available.

16.
17.

Biomarkers in cervical precancer management: the new frontiers.

Khan AM, Singer A.

Future Oncol. 2008 Aug;4(4):515-24. doi: 10.2217/14796694.4.4.515. Review.

PMID:
18684062
18.

Traditional and new molecular methods for early detection of cervical cancer.

Dallenbach-Hellweg G, Trunk MJ, von Knebel Doeberitz M.

Arkh Patol. 2004 Sep-Oct;66(5):35-9. Review.

PMID:
15575385
19.

The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments.

Bergeron C, Ronco G, Reuschenbach M, Wentzensen N, Arbyn M, Stoler M, von Knebel Doeberitz M.

Int J Cancer. 2015 Jun 15;136(12):2741-51. doi: 10.1002/ijc.28900. Epub 2014 May 12. Review.

20.

Functional biomarkers in cervical precancer: an overview.

Gupta N, Srinivasan R, Rajwanshi A.

Diagn Cytopathol. 2010 Aug;38(8):618-23. doi: 10.1002/dc.21270. Review.

PMID:
19941372
Items per page

Supplemental Content

Write to the Help Desk